Skip to main content

REGN Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Regeneron Pharmaceuticals Inc. News

Last Week Provided Good News for Cathie Wood, Ark

Ark's flagship Ark Innovation ETF has dropped 31% this year, but it has outperformed the S&P 500 over the last five years.

Cathie Wood Watch: Ark Buys Aerospace, China Car Maker; Sells Pharma

Asset manager Cathie Wood continues to buy and sell stocks amid the market's volatility. Last week, she had choice words about oil prices.

Amazon, Snap, Ford, Pinterest, And Jobs Report - Five Things You Must Know

Stock futures mixed ahead of January jobs report; Amazon shares rocket after Q4 earnings beat, Prime price hike; Ford shares slide as supply chain woes clip Q4 earnings; Snap soars as app maker transitions from Apple privacy rules and Pinterest shares leap after surprisingly solid holiday quarter revenues.

Cramer's Mad Money Recap 1/28: Alphabet, Exxon, AMD, Starbucks

Jim Cramer says investors should have their shopping list ready for the next selloff. He's got your game plan for next week.

Goldman's Strong and Weak Stocks for Fed Tightening

The strong stocks for a tightening environment include Qualcomm, Moderna, Regeneron and Louisiana-Pacific.

Breaking News

Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests

Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.

Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat

"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.

Playtika Stock Surges On Report of Joffre Capital Interest in Online Casino Gaming Group

Axios reported late Monday that tech buyout group Joffre Capital is seeking a majority stake in the online casino video game group.

Walgreens Stock Slides As Group Scraps Plan to Sell UK-based Boots

"As a result of market instability ... no third party has been able to make an offer that adequately reflects the high potential value of Boots," Walgreens said.